A 45-year-old woman from Mumbai with newly diagnosed pulmonary tuberculosis (sputum AFB positive) is started on standard four-drug regimen (HRZE). After 2 weeks of treatment, she develops a red-brown discoloration of her urine and complains of blurred vision. Her liver function tests show mild elevation of transaminases. Which drug is most likely responsible for these adverse effects, and what is the mechanism?

Explanation

## Clinical Presentation Analysis The patient presents with two distinctive findings: 1. **Red-brown discoloration of urine** (and potentially other body secretions) 2. **Blurred vision** (ocular involvement) 3. **Mild hepatotoxicity** (elevated transaminases) These findings point to a single anti-TB drug with multiple organ effects. ## Rifampicin: The Culprit Drug **Key Point:** Rifampicin is a potent inducer of cytochrome P450 enzymes and causes characteristic orange-red discoloration of body secretions (urine, tears, sweat, saliva) due to its lipophilic nature and metabolism. ### Rifampicin's Mechanism and Adverse Effects | Adverse Effect | Mechanism | Clinical Manifestation | |---|---|---| | **Orange-red discoloration** | Lipophilic drug distributes into secretions; metabolite excretion | Urine, tears, sweat, saliva turn orange-red | | **CYP450 induction** | Potent inducer of multiple cytochrome P450 isoenzymes | Reduces levels of many drugs (warfarin, OCP, protease inhibitors) | | **Hepatotoxicity** | Direct hepatic metabolism; metabolite accumulation | Transaminitis, especially with prolonged use or high doses | | **Ocular effects** | Rare but reported; related to high-dose or prolonged therapy | Blurred vision, color blindness (red-green), optic neuritis | | **Drug interactions** | CYP450 induction | Decreases efficacy of co-administered drugs | **High-Yield:** The **orange-red discoloration of urine and other body secretions is pathognomonic for rifampicin** — this is a classic NEET PG board question discriminator. Patients should be counseled that this is harmless and reversible. ## Differential Diagnosis of Anti-TB Drug Adverse Effects ```mermaid flowchart TD A[Anti-TB drug adverse effect]:::outcome --> B{Orange-red body secretions?}:::decision B -->|Yes| C[Rifampicin]:::action B -->|No| D{Peripheral neuropathy?}:::decision D -->|Yes| E[Isoniazid<br/>Pyridoxine deficiency]:::action D -->|No| F{Hyperuricemia/<br/>Gout?}:::decision F -->|Yes| G[Pyrazinamide<br/>Uric acid retention]:::action F -->|No| H{Optic neuritis/<br/>Color blindness?}:::decision H -->|Yes| I[Ethambutol<br/>Arabinosyl transferase inhibition]:::action ``` **Clinical Pearl:** Rifampicin's CYP450 induction is so potent that it reduces the efficacy of oral contraceptives — female patients must be counseled to use alternative contraception during TB therapy. ## Why This Drug Causes All Three Findings 1. **Orange-red urine:** Direct result of rifampicin's lipophilic nature and excretion in urine 2. **Blurred vision:** Rare but documented adverse effect; likely related to high drug concentration in ocular tissues 3. **Mild transaminitis:** Hepatic metabolism of rifampicin; usually reversible and not a contraindication to continue therapy unless severe **Mnemonic:** **RIFAMPICIN = Red-orange secretions, Induces CYP450, Fetal teratogen (relative caution), Affects multiple organs, Metabolized hepatically, Potent drug interactions, Induces metabolism of other drugs, Causes discoloration, Inhibits mycobacterial RNA synthesis, Nausea and hepatotoxicity** [cite:KD Tripathi 8e Ch 71]